Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
---|
09/02/1998 | EP0861666A2 Pharmaceutical composition for use in treatment of diabetes |
09/02/1998 | EP0861073A1 Stabilized thyroid hormone preparations and methods of making same |
09/01/1998 | US5801190 Fused pyrrolo 2,3-C! carbazole-6-ones |
09/01/1998 | US5801170 Heterocyclic biphenylylamides useful as 5HT1D antagonists |
09/01/1998 | US5801159 Method and composition for inhibiting cellular irreversible changes due to stress |
08/27/1998 | WO1998037111A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein |
08/27/1998 | WO1998036769A1 Pulsatile delivery of leptin receptor ligands |
08/27/1998 | WO1998036767A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands |
08/27/1998 | WO1998036763A1 Treatment of infertility with leptin receptor ligands |
08/27/1998 | WO1998036762A1 Method of modulating hypothalamic somatostatin release |
08/27/1998 | WO1998029103A3 Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation |
08/27/1998 | WO1998024802A3 Compound |
08/27/1998 | CA2282341A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands |
08/27/1998 | CA2282325A1 Pulsatile delivery of leptin receptor ligands |
08/27/1998 | CA2282323A1 Method of modulating hypothalamic somatostatin release |
08/27/1998 | CA2281888A1 Treatment of infertility with leptin receptor ligands |
08/27/1998 | CA2276339A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein |
08/26/1998 | EP0859761A1 4-azasteroids for treatment of hyperandrogenic conditions |
08/26/1998 | EP0859617A1 Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors |
08/26/1998 | EP0423326B1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient |
08/26/1998 | CN1191475A Drug delivery compositions for improved stability of steroids |
08/26/1998 | CN1191139A Liquid gonadotropin containing formulations |
08/25/1998 | US5798347 Dehydroepiandrosterone and dehydroepiandrosterone sulfate used for inhibiting proliferation of ovarian cancer |
08/25/1998 | US5798337 Low molecular weight peptidomimetic growth hormone secretagogues |
08/25/1998 | CA2122479C Risedronate delayed-release compositions |
08/20/1998 | WO1998035950A1 Benzofurazan compounds which enhance ampa receptor activity |
08/19/1998 | EP0858508A1 Novel peptides useful in enhancement of fsh action |
08/19/1998 | EP0858455A1 4-oxa and 4-thia steroids |
08/19/1998 | EP0858442A1 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity |
08/19/1998 | EP0858338A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use |
08/19/1998 | EP0858337A2 A pharmaceutical composition for the treatment of autoimmune diseases |
08/19/1998 | EP0858336A1 Method and pharmaceutical composition for regulating lipid concentration |
08/18/1998 | US5795958 Library of glyco-peptides useful for identification of cell adhesion inhibitors |
08/18/1998 | US5795957 Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone |
08/18/1998 | US5795905 CRF receptor antagonists and methods relating thereto |
08/13/1998 | WO1998034947A1 ANTIGESTAGENIC STEROIDS WITH A FLUORINATED 17α-ALKYL CHAIN |
08/13/1998 | WO1998034632A1 Compounds and compositions for delivering active agents |
08/13/1998 | WO1998034621A1 Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency |
08/13/1998 | WO1998034583A2 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones |
08/13/1998 | DE19706061A1 Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette Antiprogestin effective steroids with 17alpha-fluorinated alkyl chain |
08/13/1998 | CA2280181A1 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones |
08/13/1998 | CA2280033A1 Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency |
08/12/1998 | EP0857064A1 Stabilised pharmaceutical preparations containing thyroid hormone |
08/12/1998 | EP0696275B1 Vitamin d amide derivatives |
08/11/1998 | US5792772 Enatiomerically pure hydroxylated xanthine compounds |
08/11/1998 | US5792764 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
08/06/1998 | WO1998027113A3 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5 |
08/05/1998 | EP0855917A1 Stable pharmaceutical forms of administration containing parathormone |
08/04/1998 | US5789416 Cardiovascular and nervous system disorders |
08/04/1998 | US5789405 Oxaspiro(2,5)octane derivative |
08/04/1998 | US5788984 Gestodene-containing agent for transdermal administration |
07/30/1998 | WO1998032742A1 Novel amide derivatives and medicinal compositions thereof |
07/30/1998 | WO1998032455A1 The extract of pine needle and the use thereof |
07/30/1998 | CA2279261A1 The extract of pine needle and the use thereof |
07/29/1998 | EP0854884A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor |
07/29/1998 | EP0854715A1 Methods of inhibiting plasminogen activator inhibitor 1 |
07/29/1998 | CN1189166A Somatostatin peptides |
07/29/1998 | CN1189101A Pharmaceutical combined preparation, kit and method for hormonal contraception |
07/23/1998 | WO1998020906A3 Treatment of diabetes with transcription factor gene |
07/22/1998 | EP0853945A1 Liquid gonadotropin containing formulations |
07/22/1998 | EP0853610A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
07/22/1998 | CN1188414A Novel formulation for peptide release |
07/22/1998 | CN1188411A Compressed dry-granulation desogestrel tablets |
07/16/1998 | WO1998030590A2 Analogs of parathyroid hormone |
07/16/1998 | WO1998030556A1 Novel benzofuranone derivatives and process for producing the same |
07/16/1998 | WO1998019697A3 Novel pharmaceutical compositions |
07/15/1998 | CA2226803A1 Liquid gonadotropin containing formulations |
07/14/1998 | US5780648 Benzothiophene compounds, and uses formulations thereof |
07/14/1998 | US5780460 Therapeutic methods and delivery systems utilizing sex steroid precursors |
07/14/1998 | US5780050 Drug delivery compositions for improved stability of steroids |
07/14/1998 | US5780014 Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
07/09/1998 | WO1998029103A2 Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation |
07/09/1998 | WO1998005780A3 Voltage-gated calcium channel antagonist and methods |
07/08/1998 | EP0851925A1 Human growth hormone variants |
07/08/1998 | EP0851875A2 Dna sequences and secreted proteins encoded thereby |
07/08/1998 | EP0851759A1 Compounds and methods |
07/08/1998 | EP0851757A2 A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus |
07/08/1998 | EP0672037B1 1,4-benzodiazepine derivatives and their use as cck-modulators |
07/08/1998 | CN1187203A Method for treatment of corticosteroid induced osteopenia |
07/08/1998 | CN1187120A Composition for sustained release of human growth hormone |
07/07/1998 | US5776985 Cardiovascular disorders |
07/07/1998 | US5776923 Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
07/07/1998 | US5776901 Polypeptide analogues having growth hormone releasing activity |
07/07/1998 | US5776699 Method of identifying negative hormone and/or antagonist activities |
07/01/1998 | EP0850221A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
07/01/1998 | EP0850067A1 Method for treating cancers using 6- 3- 1-adamantyl]-4-hydroxyphenyl] |
07/01/1998 | EP0850053A1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
07/01/1998 | CN1185950A Oral composition containing dehydroepiandrosterone and its sodium sulfate |
06/30/1998 | US5773032 Long-acting injection suspensions and a process for their preparation |
06/25/1998 | WO1998027113A2 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5 |
06/25/1998 | WO1998026791A1 The use of a cimicifuga racemosa extract |
06/25/1998 | CA2275442A1 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5 |
06/23/1998 | US5770687 Comformationally constrained backbone cyclized somatostatin analogs |
06/23/1998 | US5770196 Modified antibody variable domains and therapeutic uses thereof |
06/23/1998 | CA1339924C 11beta-phenyl-14betha steroids |
06/18/1998 | WO1998025916A1 Novel benzopyran derivatives |
06/18/1998 | WO1998018430A3 P2y receptor antagonists |
06/17/1998 | EP0847755A1 Use of an extract of cimicifuga racemosa |
06/17/1998 | EP0847402A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
06/17/1998 | EP0847278A1 Analogs of parathyroid hormone |